Lonza has expanded its service offering for orally delivered biologic therapies to support the development and manufacturing needs of smart capsules companies.   Delivering biologics through an oral administration route is a growing market. Since most new drug entities face bioavailability challenges, exploring new delivery solutions to mitigate these challenges is of great value to drug developers and their patients.   Lonza aims to explore the potential of oral biologics with smart capsule...